Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia [1]

Journal of Clinical Psychiatry

Volumn 63, Issue 11, 2002, Pages 1045-

  Levy, Emmanuelle ^a   Margolese, Howard C ^a   Chouinard, Guy ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLONAZEPAM; HALOPERIDOL; LAMOTRIGINE; LOPERAMIDE; MESALAZINE; OLANZAPINE; PROCYCLIDINE; TOPIRAMATE; TRAZODONE;

ADULT; APPETITE; BODY MASS; CASE REPORT; DRUG MECHANISM; EATING HABIT; EXERCISE; HUMAN; LETTER; MALE; OBESITY; PRIORITY JOURNAL; RATING SCALE; SCHIZOPHRENIA; SIDE EFFECT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0036855308     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v63n1116a     Document Type: Letter

References (7)

1. Citrome L, Levine J, Allingham B. Changes in use of valproate and other mood stabilizers for patients with schizophrenia from 1994 to 1998. Psychiatr Serv 2000;51:634-638
2. McElroy SL, Suppes T, Keck PE, et al. Open-label adjunctive topiramate in the treatment of bipolar disorders. Biol Psychiatry 2000;47:1025-1033
3. Ghaemi SN, Gaughan S. Novel anticonvulsants: A new generation of mood stabilizers? Harv Rev Psychiatry 2000;8:1-7
4. Dursun SM, Devarajan S. Clozapine weight gain, plus topiramate weight loss [letter]. Can J Psychiatry 2000;45:198
5. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276
6. Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res 1997;35:241-256
7. Ketter TA, Post RM, Theodore WH. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999;53(suppl 2):S53-S67